AAAAAA

   
Results: 1-10 |
Results: 10
Reaching the neurons
Authors: Betdeder, D Cecchelli, R Dehouck, MP Fenart, L
Citation: D. Betdeder et al., Reaching the neurons, BIOFUTUR, 2000(196), 2000, pp. 28-31
In vitro models of the blood-brain barrier and their use in drug development
Authors: Cecchelli, R Fenart, L Buee-Scherrer, V Dehouck, B Descamps, L Duhem, C Torpier, G Dehouck, MP
Citation: R. Cecchelli et al., In vitro models of the blood-brain barrier and their use in drug development, BLOOD-BRAIN BARRIER AND DRUG DELIVERY TO THE CNS, 2000, pp. 65-75
Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity
Authors: Olivier, JC Fenart, L Chauvet, R Pariat, C Cecchelli, R Couet, W
Citation: Jc. Olivier et al., Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity, PHARM RES, 16(12), 1999, pp. 1836-1842
In vitro model for evaluating drug transport across the blood-brain barrier
Authors: Cecchelli, R Dehouck, B Descamps, L Fenart, L Buee-Scherrer, V Duhem, C Lundquist, S Rentfel, M Torpier, G Dehouck, MP
Citation: R. Cecchelli et al., In vitro model for evaluating drug transport across the blood-brain barrier, ADV DRUG DE, 36(2-3), 1999, pp. 165-178
Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier
Authors: Fenart, L Casanova, A Dehouck, B Duhem, C Slupek, S Cecchelli, R Betbeder, D
Citation: L. Fenart et al., Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier, J PHARM EXP, 291(3), 1999, pp. 1017-1022
Transport of cationized anti-tetanus Fab ' 2 fragments across an in vitro blood-brain barrier model: Involvement of the transcytosis pathway
Authors: Girod, J Fenart, L Regina, A Dehouck, MP Hong, GY Scherrmann, JM Cecchelli, R Roux, F
Citation: J. Girod et al., Transport of cationized anti-tetanus Fab ' 2 fragments across an in vitro blood-brain barrier model: Involvement of the transcytosis pathway, J NEUROCHEM, 73(5), 1999, pp. 2002-2008
Receptor-mediated transcytosis of cyclophilin B through the blood-brain barrier
Authors: Carpentier, M Descamps, L Allain, F Denys, A Durieux, S Fenart, L Kieda, C Cecchelli, R Spik, G
Citation: M. Carpentier et al., Receptor-mediated transcytosis of cyclophilin B through the blood-brain barrier, J NEUROCHEM, 73(1), 1999, pp. 260-270
Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid
Authors: Bernoud, N Fenart, L Moliere, P Dehouck, MP Lagarde, M Cecchelli, R Lecerf, J
Citation: N. Bernoud et al., Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid, J NEUROCHEM, 72(1), 1999, pp. 338-345
Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier
Authors: Fillebeen, C Descamps, L Dehouck, MP Fenart, L Benaissa, M Spik, G Cecchelli, R Pierce, A
Citation: C. Fillebeen et al., Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier, J BIOL CHEM, 274(11), 1999, pp. 7011-7017
Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier
Authors: Chopineau, J Robert, S Fenart, L Cecchelli, R Lagoutte, B Paitier, S Dehouck, MP Domurado, D
Citation: J. Chopineau et al., Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier, J CONTR REL, 56(1-3), 1998, pp. 231-237
Risultati: 1-10 |